MX2022004295A - Extractos terapeuticos de cannabis. - Google Patents

Extractos terapeuticos de cannabis.

Info

Publication number
MX2022004295A
MX2022004295A MX2022004295A MX2022004295A MX2022004295A MX 2022004295 A MX2022004295 A MX 2022004295A MX 2022004295 A MX2022004295 A MX 2022004295A MX 2022004295 A MX2022004295 A MX 2022004295A MX 2022004295 A MX2022004295 A MX 2022004295A
Authority
MX
Mexico
Prior art keywords
remainder
supplemented
fraction
cannabis extracts
cannabis
Prior art date
Application number
MX2022004295A
Other languages
English (en)
Inventor
James Castillo
Original Assignee
Jenny´S Rose Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jenny´S Rose Llc filed Critical Jenny´S Rose Llc
Publication of MX2022004295A publication Critical patent/MX2022004295A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/67—Piperaceae (Pepper family), e.g. Jamaican pepper or kava

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención puede ser una de varias formulaciones que contienen cannabinoides y compuestos no cannabinoides complementados con una fracción "restante". Las plantas de cannabis se someten a una extracción, y el extracto resultante puede complementarse con ingredientes adicionales para conseguir el perfil químico deseado. La adición de la fracción "restante" mejora o aumenta la eficiencia o eficacia de la fórmula. La valoración de la dosis puede ser utilizada para encontrar una dosis apropiada o adecuada de extracto de cannabis que se ingiera para tratar condiciones médicas.
MX2022004295A 2019-10-08 2020-10-08 Extractos terapeuticos de cannabis. MX2022004295A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16/596,287 US10946054B1 (en) 2019-10-08 2019-10-08 Therapeutic cannabis extracts
PCT/US2020/054734 WO2021072045A1 (en) 2019-10-08 2020-10-08 Therapeutic cannabis extracts

Publications (1)

Publication Number Publication Date
MX2022004295A true MX2022004295A (es) 2022-07-12

Family

ID=73030237

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022004295A MX2022004295A (es) 2019-10-08 2020-10-08 Extractos terapeuticos de cannabis.

Country Status (6)

Country Link
US (2) US10946054B1 (es)
EP (1) EP4041221A1 (es)
CA (1) CA3154070A1 (es)
CO (1) CO2022005549A2 (es)
MX (1) MX2022004295A (es)
WO (1) WO2021072045A1 (es)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2377218A (en) 2001-05-04 2003-01-08 Gw Pharmaceuticals Ltd Process and apparatus for extraction of active substances and enriched extracts from natural products
US20170340562A9 (en) * 2014-05-12 2017-11-30 Hddc Holdings Llc Cannabinoid caffeinated drinks, powder, beans, and cannabinoid loose tea leaf
WO2016044370A1 (en) * 2014-09-16 2016-03-24 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
US11117852B2 (en) 2017-04-05 2021-09-14 University Of Mississippi Isolation of pure cannabinoids from Cannabis
AU2018100837B4 (en) * 2017-06-19 2019-02-21 Zelira Therapeutics Operations Pty Ltd Sleep Disorder Compositions and Treatments Thereof

Also Published As

Publication number Publication date
CA3154070A1 (en) 2021-04-15
US20210196774A1 (en) 2021-07-01
CO2022005549A2 (es) 2022-05-20
WO2021072045A1 (en) 2021-04-15
EP4041221A1 (en) 2022-08-17
US20210100862A1 (en) 2021-04-08
US10946054B1 (en) 2021-03-16

Similar Documents

Publication Publication Date Title
MX2019000427A (es) Formas de dosificacion oral de cannabinoide de alta concentracion.
MX2021000814A (es) Uso de cannabinoides en el tratamiento de epilepsia.
MX2019001286A (es) Composicion de cannabis.
MX2021000020A (es) Composicion y metodo para tratar el dolor.
MX2021006094A (es) Uso de cannabinoides en el tratamiento de epilepsia.
WO2014188276A3 (en) Antioxidant compositions and methods of using the same
WO2019199861A3 (en) Hemp extract for treatment of pain in animals
MX344787B (es) Composiciones que contienen berberina o analogos de la misma para tratar rosacea o trastornos de la piel relacionados con enrojecimiento de la cara.
MX2017015012A (es) Formulaciones tópicas y orales que comprenden taurina y magnesio para la prevención y el tratamiento del acné.
M Barbalho et al. Annona sp: Plants with multiple applications as alternative medicine-A Review
MX2021014158A (es) Uso de cannabidiol en el tratamiento de espasmos epilepticos.
SG11201908234WA (en) Pharmaceutical composition comprising compound capable of penetrating blood-brain barrier as effective ingredient for preventing or treating brain cancer
MY189342A (en) Treatment and prevention of the common cold using povidone-iodine
IN2014MN01973A (es)
MX2023005550A (es) Inhibidores de diclorofenol hsd17b13 y usos de los mismos.
MX2022004257A (es) Composicion farmaceutica y metodo para tratamiento de los trastornos convulsionales.
MX2019007213A (es) Derivado de azaciclobutil triazol del grupo anular condensado, metodo de preparacion del mismo y uso del mismo en medicina.
MX2019002047A (es) Metodos y composiciones para tratar infecciones fungicas cutaneas.
MX2016016400A (es) Formulaciones de oximetazolina estabilizadas y sus usos.
RU2012112399A (ru) Композиция и способ для восстановления кожи
NZ760781A (en) Process for the preparation of standardized composition of arjunoglucoside from the bark of terminalia arjuna
MX2022004295A (es) Extractos terapeuticos de cannabis.
WO2016088030A1 (en) Buchu preparations
MX2021003651A (es) Formulacion que comprende aceite ozonizado en el tratamiento de un tumor.
Kádasi et al. Effect of natural plant extracts on porcine ovarian functions.